Health
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the Company will ...
2025-11-07 08:10
1128
Australian Sleep Tech Company Launches a Smart Ring to Transform Sleep & Health - retimer Ring
ADELAIDE, Australia, Nov. 7, 2025 /PRNewswire/ -- Re-Time Pty Ltd (RTPL) today announced the launch of the retimer Ring, the first smart ring solution developed by an Australian company to help people improve sleep and overall wellbeing. Building on a legacy of more than 25 years of research at F...
2025-11-07 07:00
1290
Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally
SYDNEY, Nov. 7, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation
oncology workflow solutions, today announced the close of itsA$25 million
Series B financing round. The round was led by Aviron Investment Management
with continued participation from Oncology Ventures.
2025-11-07 06:00
1207
UPL launches a global campaign '#AFarmerCan' ahead of COP30, championing farmers in climate action
~ A global call to action urging world leaders to place farmers at the heart of
climate strategies
Microsite: Meet 20 farmers from around the world leading climate action in
agriculture
2025-11-07 01:53
1252
Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations
– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients – BASEL, Switzerland, Nov. 6, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality ingredients from natural sources, today announced the successful cl...
2025-11-06 22:00
1050
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
BELLEVUE, Wash., Nov. 6, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key findings from a company-sponsored pilot study conducted by Woori IO, an OSR Company, in collaboration with Korea University Guro Hospital. The study, which took place fromMay 9 to September 12,...
2025-11-06 21:30
1298
KGC Launches Premium Ingredient Brand "G1899," for the Global B2B Health Ingredient Market
* KGC, a Global Health Leader, Expands into the B2B Ingredient Sector with Its Standardized Premium Brand "G1899" * Showcases "G1899" at the World's Largest Ingredient Exhibition, SSG 2025, Highlighting the Excellence of Red Ginseng * Demonstrates KGC's Quality Management Systems and Advanc...
2025-11-06 21:00
1175
Uniting Global Minds to Shape the Future of Healthcare -- The 3rd CREATE Symposium Opens in Hong Kong
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- In the era of artificial intelligence, the rapid advancements in AI and robotics are revolutionizing healthcare — reshaping diagnosis, treatment, and health management. How to deeply integrate these cutting-edge technologies into clinical practice, and tran...
2025-11-06 18:06
1345
Millennium Technology Prize opens its nomination period for innovations for a better life
HELSINKI, Nov. 6, 2025 /PRNewswire/ -- The world's leading innovation award, Millennium Technology Prize, will be awarded again inMay 2027. The eligibility criteria of the prize have been expanded to even more future-oriented innovations that improve the well-being of humankind and the planet and...
2025-11-06 16:15
940
Leading Fertility Specialist Associate Professor Gavin Sacks joins Genea
SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate ProfessorGavin Sacks, to its medical leadership team, continuing the organisation's 40-year tradition ...
2025-11-06 16:09
1000
KT&G sees record quarterly revenue and operating profit in Q3, raises guidance based on double-digit growth
* Quarterly global cigarette revenue surpasses KRW 500 billion for the first time; cigarette& NGP performs solidly hand-in-hand * Acquires ASF jointly with Altria, modern product's global expansion to gain momentum SEOUL, South Korea, Nov. 6, 2025 /PRNewswire/ -- KT&G (KRX: 033780) presented ...
2025-11-06 15:49
2370
International Symposium on Myofunctional Therapy Concludes Successfully in Shanghai, Strengthening Global Collaboration in Functional Orthodontics
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- The International Symposium on Myofunctional Therapy in Multidisciplinary Collaboration, hosted by the Chinese Association of Orofacial Myology (CHAOM) and supported by Smartee Denti-Technology, concluded successfully inShanghai. The event brought together ...
2025-11-06 15:35
942
Fosun Marks Eighth Year at CIIE, Guo Guangchang Calls for More Cutting-Edge Innovation
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center (Shanghai). As a "full-attendance" exhibitor for eight consecutive years, Fosun, together with its overseas member companies and glob...
2025-11-06 15:19
2135
MediTrust Health Shares Insights at Hong Kong Fintech Week: AI Pragmatically Reshaping Cross-Border Healthcare Payments in the Greater Bay Area
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- MediTrust Health, the largest innovative healthcare payor platform inChina, delivered key insights recently at the HealthTech Forum of "Hong Kong FinTech Week 2025."Seth Zhang, Founder and CEO of MediTrust Health, stated that Artificial Intelligence (AI) i...
2025-11-06 14:53
1163
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthro...
2025-11-06 14:11
1130
THE ADECCO GROUP Q3 2025 RESULTS
AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 /PRNewswire/ -- HIGHLIGHTS * Further strong market share gains, Group +375 bps and Adecco +300 bps * Group revenues +3.4% yoy, and +3...
2025-11-06 13:45
872
Alphamab Oncology Showcases Cutting-edge Breakthroughs and Innovative Achievements at the 16th World ADC San Diego
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders inSan Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-...
2025-11-06 12:05
1007
The 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) will be held in Kunming, presenting a new landscape of integrated cancer prevention and treatment from a global perspective.
KUNMING, China, Nov. 5, 2025 /PRNewswire/ -- From November 6 to 9, 2025, the highly anticipated 2025 CCHIO will be grandly held in Kunming, the "Spring City". Hosted by the Chinese Anti-Cancer Association and the Secretariat of the Tengchong Scientists Forum Organizing Committee, co-hosted by the...
2025-11-06 10:58
952
New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia
* Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The first healthcare simulation certification programmes designed specifically for Southeas...
2025-11-06 10:13
964
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia
Patient, Demonstrating Excellent Safety and Significant Efficacy
SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai,
China, CorrectSequence Therapeutics Co., Ltd. (Correctseq
2025-11-06 08:00
1164
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00
2025 Guangzhou Design Week Opens: PHOMI Holdings Leads Tech Innovation in Architectural Aesthetics
[Picked up by 287 media titles]
2025-12-06 10:37
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4965
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
4050
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3932
Dreame Technology Recognized on Fast Company's List of Brands That Matter
2025-12-06 01:30
3444
Cyient Semiconductors Qualifies for Key Bid in Semi-Conductor Laboratory-Mohali Revamp
2025-12-06 02:00
2687